PHARMACOKINETICS AND DISPOSITION

[1]  J. Levy.  TREATMENT OF PERIOPERATIVE HYPERTENSION , 1999 .

[2]  C. Regårdh,et al.  Clinical and pharmacokinetic results with a new ultrashort-acting calcium antagonist, clevidipine, following gradually increasing intravenous doses to healthy volunteers. , 1999, British journal of clinical pharmacology.

[3]  C. Regårdh,et al.  In vitro hydrolysis rate and protein binding of clevidipine, a new ultrashort-acting calcium antagonist metabolised by esterases, in different animal species and man. , 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[4]  M Danhof,et al.  Relevance of arteriovenous concentration differences in pharmacokinetic-pharmacodynamic modeling of midazolam. , 1998, The Journal of pharmacology and experimental therapeutics.

[5]  T. Nishikawa,et al.  A132 ARTERIAL BAROREFLEX FUNCTION IN HUMANS ANESTHETIZED WITH SEVOFLURANE , 1997 .

[6]  D. Fisher.  (Almost) everything you learned about pharmacokinetics was (somewhat) wrong! , 1996, Anesthesia and analgesia.

[7]  J. Dienstag,et al.  Pharmacokinetics and Pharmacodynamics of Remifentanil in Volunteer Subjects with Severe Liver Disease , 1996, Anesthesiology.

[8]  J. Chism,et al.  The pharmacokinetics and extra-hepatic clearance of remifentanil, a short acting opioid agonist, in male beagle dogs during constant rate infusions. , 1996, Drug metabolism and disposition: the biological fate of chemicals.

[9]  J. Levy,et al.  The ideal agent for perioperative hypertension and potential cytoprotective effects , 1993, Acta anaesthesiologica Scandinavica. Supplementum.

[10]  P. A. Zwieten,et al.  Antihypertensive drug treatment in the perioperative period , 1993 .

[11]  S. Tabata,et al.  Metabolic Fate of Felodipine in Man , 1992 .

[12]  C. Regårdh,et al.  Pharmacokinetics and biotransformation of 1,4-dihydropyridine calcium antagonists , 1990 .

[13]  W. L. Chiou,et al.  The Phenomenon and Rationale of Marked Dependence of Drug Concentration on Blood Sampling Site , 1989, Clinical pharmacokinetics.

[14]  R. Gray,et al.  Postcardiac surgical hypertension. , 1988, Journal of cardiothoracic anesthesia.

[15]  H. Wollersheim,et al.  Intravenous Nicardipine in Raynaud's Phenomenon: A Controlled Trial , 1988, Journal of cardiovascular pharmacology.

[16]  J. Urquhart,et al.  Rate of increase in the plasma concentration of nifedipine as a major determinant of its hemodynamic effects in humans , 1987, Clinical pharmacology and therapeutics.

[17]  L. Svensson,et al.  Use of dodecyl sulfate as an esterase inhibitor before gas-chromatographic determination of labile beta-adrenoceptor blocking drugs. , 1985, Clinical chemistry.

[18]  J. Tinker,et al.  Hemodynamic and adrenergic responses to anesthesia and operation for myocardial revascularization. , 1980, The Journal of thoracic and cardiovascular surgery.

[19]  I. Dimich,et al.  Sympathetic nervous system tonicity and post-coronary artery bypass hypertension. , 1981, Acta anaesthesiologica Scandinavica.

[20]  S. Oparil,et al.  Pathogenesis of paroxysmal hypertension developing during and after coronary bypass surgery: a study of hemodynamic and humoral factors. , 1980, The American journal of cardiology.

[21]  T. N. James,et al.  Anatomic and physiologic considerations of a cardiogenic hypertensive chemoreflex. , 1979, The American journal of cardiology.

[22]  R. Tarazi,et al.  Acute hypertension immediately after coronary artery surgery. , 1977, The Journal of thoracic and cardiovascular surgery.

[23]  Malcolm Rowland,et al.  Pharmacokinetics of Acetylsalicylic Acid and Salicylic Acid After Intravenous Administration in Man , 1968 .